Figure 2. Associations of higher genetically predicted Fibroblast Growth Factor 21 (FGF21) concentration with cardiometabolic diseases, Alzheimer’s disease and lifespan. Estimates are scaled per additional FGF21-increasing allele of rs838133. CI: confidence interval; OR: odds ratio.
Table 1. Data sources for the outcome phenotypes included in the present Mendelian randomization study